ArticleCureus2024
Extracorporeal Membrane Oxygenation in the Management of Takotsubo Cardiomyopathy Secondary to Mitral Valve Replacement Surgery: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unlike classical myocardial infarction, acute emotional or physical stress can trigger distinct but transient wall motion abnormalities with patent coronary arteries. Takotsubo cardiomyopathy (TC) classically presents as systolic and diastolic left ventricular (LV) dysfunction, which is widely accepted to be secondary to catecholamine-induced microvascular dysfunction. Our case report describes a 26-year-old female undergoing mitral valve replacement (MVR) surgery for infective endocarditis and postoperatively developing TC. Severe hemodynamic instability with low mean arterial pressure necessitated emergency intubation and ventilation. Bedside formal echocardiography reported mid and apical segment akinesia with significant left ventricular systolic dysfunction. This case identifies a potential cause of sudden-onset heart failure (HF) in patients with critical illness. The early recognition and appropriate management of TC are highlighted in this article, particularly in high-risk patients undergoing cardiac surgery. In recent years, extracorporeal membrane oxygenation (ECMO) has presented a unique opportunity to mechanically manipulate pulmonary vascular pressure. TC is a unique and uncommon cause of sudden-onset heart failure in patients with critical illnesses. This article illustrates the importance of the early recognition and management of TC with ECMO. Considering the rarity of TC, randomized controlled trials are yet to establish optimal management strategies for specific etiology. Further research and case series are vital to enhance our understanding of the vital use of ECMO in the treatment of takotsubo cardiomyopathy secondary to MVR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.